Skip to main content

Currently Skimming:

5 Managing Conflict and Facilitating Innovation
Pages 39-48

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 39...
... • Greater alignment of incentives with research goals could reduce conflict of interest challenges. • New models for managing conflict of interest policies could be tested in the precompetitive space to determine if they align with institutional goals.
From page 40...
... Throughout the workshop, individual speakers who represented patient advocates, regulators, academic researchers, and industry stakeholder groups discussed alignment of incentives in the broader research ecosystem, increasing public knowledge about conflict of interest policies, and the need to keep patients as a priority (see Box 5-1)
From page 41...
... MANAGING CONFLICTS OF INTEREST AND BALANCING INNOVATION AT INSTITUTIONS According to Chisolm, commercialization of medical innovations can improve the lives of patients, generate revenue, and support the economic revival of cities. These goals are supported through an aggressive commercialization arm and an effort to recruit, retain, and reward an innovative staff at the Cleveland Clinic, said Chisolm.
From page 42...
... Today, Johns Hopkins University is working with the Coulter Foundation to set up innovative groups of biomedical engineers working with clinicians to build companies to deliver products to patients. The university's Brain Science Institute supports the translation of therapies for brain diseases through an interdisciplinary research team.
From page 43...
... Some situations are similar to managing conflicts in individual grants, though multiple projects are involved. In other cases the collaborations are more open-ended and may be more difficult to manage.
From page 44...
... Potential Solutions for Conflict of Interest Policies The Council of Medical Specialty Societies (CMSS) ,1 which is an organization composed of 39 leading medical societies, has developed a code of conduct2 for interacting with industry for use by its medical society members, and additional organizations have been signing on.
From page 45...
... [That] would make a lot of this process less burdensome and therefore more attractive for more people." ALIGNING INCENTIVES IN THE RESEARCH ECOSYSTEM Terry observed that many of the issues surrounding conflicts of interest arise because incentives are not aligned with goals and that where incentives are aligned with goals, fewer problems arise.
From page 46...
... Chisolm observed that information disseminated by the Physician Payments Sunshine Act is going to generate questions, but these questions provide an opportunity for public education about the nature, benefits, and risks of industry partnerships with academia. Lichter predicted that disseminated disclosure information would not be damaging.
From page 47...
... Advocates may be nonvoting members of panels, but their voices need to be better incorporated into the decision-making process, she said. Recent legislation directed FDA to incorporate patient voices into its regulatory decision making, and the agency has an initiative designed to explore methodologies for measuring patient preferences.
From page 48...
... Everyone at the workshop, whether representing government, industry, or academia, also represents a patient who needs care, Terry said, and all of them therefore have an interest in improving patients' lives through the management of productive relationships that allow collaborations to move forward. "The urgency we feel when we're sick or when our parents are sick or when our children are sick, is the urgency we need to bring forward into all these conversations and actions."


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.